Axsome Therapeutics, Inc.
SEC Filing List
AXSM CIK: 0001579428
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 144 | Filing for proposed sale of securities u... | Goldman Sachs & Co. LLC /FA | 05/05/2026 | ||
| 4 | Statement of changes in beneficial owner... | Jacobson Mark L. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/05/2026 | |
| 144/A | Amendment to Filing for proposed sale of... | Goldman Sachs & Co. LLC /FA | 05/05/2026 | ||
| 8-K | Current report filing | Axsome Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/04/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Axsome Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/04/2026 | |
| 144 | Filing for proposed sale of securities u... | Goldman Sachs & Co. LLC /FA | 05/04/2026 | ||
| 8-K | Current report filing | Axsome Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/30/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Axsome Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/24/2026 | |
| ARS | Annual report to security holders | Axsome Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/24/2026 | |
| DEF 14A | Definitive proxy statements | Axsome Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/24/2026 | |
| No record found. | |||||
| Load More | |||||
